102 related articles for article (PubMed ID: 9072127)
21. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
22. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G
Respiration; 2007; 74(1):19-25. PubMed ID: 16675894
[TBL] [Abstract][Full Text] [Related]
23. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
24. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.
Eller J; Ede A; Schaberg T; Niederman MS; Mauch H; Lode H
Chest; 1998 Jun; 113(6):1542-8. PubMed ID: 9631791
[TBL] [Abstract][Full Text] [Related]
25. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.
Soler N; Torres A; Ewig S; Gonzalez J; Celis R; El-Ebiary M; Hernandez C; Rodriguez-Roisin R
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1498-505. PubMed ID: 9603129
[TBL] [Abstract][Full Text] [Related]
26. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
27. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
[TBL] [Abstract][Full Text] [Related]
28. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
[TBL] [Abstract][Full Text] [Related]
29. Ampicillin resistance in
Maddi S; Kolsum U; Jackson S; Barraclough R; Maschera B; Simpson KD; Pascal TG; Durviaux S; Hessel EM; Singh D
Int J Chron Obstruct Pulmon Dis; 2017; 12():1507-1518. PubMed ID: 28579769
[TBL] [Abstract][Full Text] [Related]
30. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction.
Fruchter O; Rosengarten D; Goldberg E; Ben-Zvi H; Tor R; Kramer MR
Clin Respir J; 2016 Mar; 10(2):239-45. PubMed ID: 25196428
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
32. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease.
Bresser P; Out TA; van Alphen L; Jansen HM; Lutter R
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):947-52. PubMed ID: 10988111
[TBL] [Abstract][Full Text] [Related]
33. Obstructive lung disease in acute medical patients.
Seemungal T; Harrinarine R; Rios M; Abiraj V; Ali A; Lacki N; Mahabir N; Ramoutar V; King CP; Bhowmik A; Wedzicha JA
West Indian Med J; 2008 Jan; 57(1):7-13. PubMed ID: 19565931
[TBL] [Abstract][Full Text] [Related]
34. Haemophilus influenzae and haemophilus parainfluenzae in chronic obstructive pulmonary disease.
Smith CB; Golden CA; Kanner RE; Renzetti AD
Lancet; 1976 Jun; 1(7972):1253-5. PubMed ID: 73690
[TBL] [Abstract][Full Text] [Related]
35. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease.
Kristan SS; Marc MM; Kern I; Flezar M; Suskovic S; Kosnik M; Korosec P
Scand J Immunol; 2012 Jan; 75(1):109-14. PubMed ID: 21916917
[TBL] [Abstract][Full Text] [Related]
36. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.
Miravitlles M; Mayordomo C; Artés M; Sánchez-Agudo L; Nicolau F; Segú JL
Respir Med; 1999 Mar; 93(3):173-9. PubMed ID: 10464874
[TBL] [Abstract][Full Text] [Related]
37. Microbes responsible for acute exacerbation of COPD.
Bari MR; Hiron MM; Zaman SM; Rahman MM; Ganguly KC
Mymensingh Med J; 2010 Oct; 19(4):576-85. PubMed ID: 20956903
[TBL] [Abstract][Full Text] [Related]
38. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
[TBL] [Abstract][Full Text] [Related]
39. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.
Sibila O; Garcia-Bellmunt L; Giner J; Rodrigo-Troyano A; Suarez-Cuartin G; Torrego A; Castillo D; Solanes I; Mateus EF; Vidal S; Sanchez-Reus F; Sala E; Cosio BG; Restrepo MI; Anzueto A; Chalmers JD; Plaza V
Ann Am Thorac Soc; 2016 May; 13(5):636-42. PubMed ID: 26882402
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for lower airway bacterial colonization in chronic bronchitis.
Monsó E; Rosell A; Bonet G; Manterola J; Cardona PJ; Ruiz J; Morera J
Eur Respir J; 1999 Feb; 13(2):338-42. PubMed ID: 10065678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
